Biotech Ventures

From Scientific Insight to Investable Opportunity

A 12-week, live online program for scientists, clinicians, entrepreneurs, and investment professionals who want to develop, evaluate, finance, or commercialize biotechnology ventures.

Spring 2027 Cohort
Wednesdays, February 3–May 5, 2027
6:30–9:00 p.m. Eastern Time
Live online with session recordings
No sessions April 21 or April 28

Academic Tuition: $650
For eligible students, postdoctoral researchers, faculty, and academic participants.

ENROLL — ACADEMIC | $650

Professional Tuition: $1,500
For clinicians, scientists, entrepreneurs, investors, consultants, and industry professionals.

ENROLL — PROFESSIONAL | $1,500

Turn Scientific Potential into a Commercial Strategy

Biotechnology ventures require more than promising science. Participants must understand unmet need, intellectual property, clinical and regulatory pathways, market adoption, financing, valuation, and investment readiness.

During this program, participants will develop or evaluate a biotechnology opportunity and build an integrated scientific, commercial, and financing strategy.

What You Will Learn:

• Identify and assess promising biotechnology opportunities

• Connect scientific evidence with unmet clinical or market needs

• Evaluate intellectual property, regulatory, clinical, and reimbursement considerations

• Examine commercialization, business-model, and market-entry choices

• Raise capital, apply financial, valuation, and investment-analysis frameworks

• Use AI-enabled methods to support research, diligence, and decision-making

• Present a coherent venture or investment opportunity to potential stakeholders

Program Structure

Part I — Biotechnology Foundations and Opportunity Selection
Scientific platforms, unmet needs, evidence quality, and opportunity selection.

Part II — Development and Commercialization
Intellectual property, product development, regulatory strategy, market validation, manufacturing, and commercialization.

Part III — AI-Enabled Biotechnology Investing
Due diligence, financing, valuation, investment strategy, and venture presentation.

The detailed instructional framework and proprietary course materials are provided to enrolled participants.

Who Should Enroll?

• Scientists, physicians, and other clinicians

• Graduate and advanced undergraduate science students

• Postdoctoral researchers and engineers

• Biotechnology founders and aspiring entrepreneurs

• Technology-transfer and commercialization professionals

• Investors, analysts, consultants, and deal professionals

• Professionals entering the biotechnology sector

No single background is expected. The cohort is deliberately interdisciplinary.

Program Director

Everton S. Latty, PhD

Dr. Latty previously served as Course Director and Lecturer for Biotechnology Enterprise at Johns Hopkins University, where earlier participants developed more than 18 investor-ready scientific ventures material. He also previously taught Venture Capital and Private Equity in Howard University’s MBA program.

His multidisciplinary background spans biotechnology, data science, finance, venture development, investment analysis, and commercialization strategy.

Selected scientific and industry specialists may participate as guest instructors or reviewers, subject to availability.

Tuition Includes

• Twelve live online instructional sessions

• Access to session recordings

• Course materials and applied frameworks

• Venture-development and evaluation exercises

• Selected group laboratory or office-hour sessions

• Certificate of Completion

Enroll in the Spring 2027 Cohort

Choose the applicable enrollment category below. Payment is processed securely through Stripe.

ENROLL — ACADEMIC | $650

ENROLL — PROFESSIONAL | $1,500

Enrollment is limited. The cohort is subject to minimum participation. If SEGP Academy cancels the cohort, tuition payments will be refunded in full.

Questions or institutional enrollment inquiries:

academy@silver-equity.com
SEGP Academy | Silver Equity Growth Partners